Hints and tips:
Related Special Reports
...Noom has 3,000 health coaches worldwide that are assigned to hundreds of clients at a time and expected to respond to messages within 48 hours using the in-app service....
...The UK’s National Health Service is participating in a clinical trial of the Galleri test involving 140,000 patients....
...This enabled Indonesia to optimise its debt-service levels in the face of volatile markets....
...Wise also pointed to Ortho Clinical Diagnostics, which Carlyle spun out of US drugmaker Johnson & Johnson in 2014....
...The tests are still undergoing clinical trials....
...The first impacts of big data and machine learning on healthcare have come in operational areas, rather than in clinical settings....
...After an initial safety trial, there must now be larger clinical studies to test efficacy....
...The scandal echoes the controversy when DeepMind, a London-based unit of Google, partnered with a National Health Service trust....
...Google was one of many technology companies that had been trying to change healthcare; it had abandoned its medical records service in 2011....
...That device, called IDx-DR, was manufactured by Iowa-based IDx LLC....
...This has allowed the city to operate at a scale that is rare in the National Health Service....
...Apple is using its Watch as a platform for digital health services, including clinical research projects, while it is also testing a feature to allow iPhone owners in the US to download electronic medical...
...David Greenfield, a clinical psychologist who founded the Connecticut-based Center for Internet and Technology Addiction, is pushing for greater education....
...The company was struggling: its shares had plummeted after the US Food and Drug Administration put a partial clinical hold on enrolment for trials of its leukaemia drug, Iclusig, over concerns it caused...
...Researchers say much scientific, regulatory and political work needs to be done before they begin clinical trials....
...The class-action lawsuit tied to Elan Corp alleged that SAC and Mr Cohen, along with money manager Mathew Martoma, traded on inside information related to a clinical trial of an Alzheimer’s disease drug...
...Telecommunications and industrial stocks performed well, too, while the healthcare sector struggled after biotech heavyweight Biogen said a potential multiple sclerosis drug failed in a mid-stage clinical...
...Like AFGlobal, Medidata Solutions, a clinical technology company, fell victim to email fraud in September 2014....
...“I revealed the results of the clinical trial with respect to its efficacy,” just before it was publicly announced, Mr Gilman told the jury....
...Mr Martoma, a former portfolio manager for SAC, “sought out an illegal edge”, prosecutor Arlo Devlin Brown told the jury, when he contacted two medical doctors hired to participate in a clinical trial for...
...The three-week trial revealed what prosecutor Arlo Devlin Brown called the “underbelly of an industry”, referring to the casual ways in which some doctors shared insights into confidential clinical drug...
...The prosecution’s case is based heavily on the testimony of two doctors – Dr Sidney Gilman and Dr Joel Ross – who were hired by Elan to consult on a clinical drug trial the company ran jointly with Wyeth...
...Mathew Martoma, a former SAC money manager, is due to face trial on January 6 for allegedly trading drug company stocks in advance of negative clinical trial results. He has pleaded not guilty....
...office this week opened its case against Matthew Martoma, the former SAC Capital portfolio manager who has pleaded not guilty to trading in drug company shares after learning the confidential results of a clinical...
...Mr Martoma has pleaded not guilty to allegations that he traded shares of Wyeth and Elan Pharmaceuticals after he learnt from a doctor advising on a clinical drug trial that the results would disappoint....
International Edition